141 related articles for article (PubMed ID: 38664548)
1. Baseline CD4
Massa C; Karn T; Weber K; Schneeweiss A; Hanusch C; Uwe Blohmer J; Zahm DM; Jackisch C; Mackelenbergh MV; Thomalla J; Marmé F; Huober J; Müller V; Schem C; Müller A; Stickeler E; Biehl K; Fasching PA; Untch M; Loibl S; Denkert C; Seliger B
Clin Transl Med; 2024 Apr; 14(4):e1617. PubMed ID: 38664548
[No Abstract] [Full Text] [Related]
2. Improving Immunotherapy Against B-Cell Malignancies Using γδ T-Cell-specific Stimulation and Therapeutic Monoclonal Antibodies.
Hoeres T; Pretscher D; Holzmann E; Smetak M; Birkmann J; Triebel J; Bertsch T; Wilhelm M
J Immunother; 2019; 42(9):331-344. PubMed ID: 31318724
[TBL] [Abstract][Full Text] [Related]
3. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
Front Immunol; 2021; 12():687961. PubMed ID: 34335589
[TBL] [Abstract][Full Text] [Related]
4. Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity.
Siegers GM; Dutta I; Kang EY; Huang J; Köbel M; Postovit LM
Front Immunol; 2020; 11():1287. PubMed ID: 32636849
[TBL] [Abstract][Full Text] [Related]
5. Avelumab, an IgG1 anti-PD-L1 Immune Checkpoint Inhibitor, Triggers NK Cell-Mediated Cytotoxicity and Cytokine Production Against Triple Negative Breast Cancer Cells.
Juliá EP; Amante A; Pampena MB; Mordoh J; Levy EM
Front Immunol; 2018; 9():2140. PubMed ID: 30294328
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a stromal immune phenotype classifier for predicting immune activity and prognosis in triple-negative breast cancer.
Zheng S; Zou Y; Xie X; Liang JY; Yang A; Yu K; Wang J; Tang H; Xie X
Int J Cancer; 2020 Jul; 147(2):542-553. PubMed ID: 32285442
[TBL] [Abstract][Full Text] [Related]
7. Combining Chemotherapy and Immunotherapy for the Treatment of Triple-Negative Breast Cancer.
McArthur H
Oncology (Williston Park); 2019 Apr; 33(4):137-40. PubMed ID: 30990566
[No Abstract] [Full Text] [Related]
8. γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends.
Barros MS; de Araújo ND; Magalhães-Gama F; Pereira Ribeiro TL; Alves Hanna FS; Tarragô AM; Malheiro A; Costa AG
Front Immunol; 2021; 12():729085. PubMed ID: 34630403
[TBL] [Abstract][Full Text] [Related]
9. Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial.
Graeser M; Feuerhake F; Gluz O; Volk V; Hauptmann M; Jozwiak K; Christgen M; Kuemmel S; Grischke EM; Forstbauer H; Braun M; Warm M; Hackmann J; Uleer C; Aktas B; Schumacher C; Kolberg-Liedtke C; Kates R; Wuerstlein R; Nitz U; Kreipe HH; Harbeck N
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33963012
[TBL] [Abstract][Full Text] [Related]
10. Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer.
Nakhjavani M; Shigdar S
Pharmacol Res; 2022 Jan; 175():106019. PubMed ID: 34861397
[TBL] [Abstract][Full Text] [Related]
11. Bispecific Antibodies for Triple Negative Breast Cancer.
Dees S; Ganesan R; Singh S; Grewal IS
Trends Cancer; 2021 Feb; 7(2):162-173. PubMed ID: 33041246
[TBL] [Abstract][Full Text] [Related]
12. Regression of Triple-Negative Breast Cancer in a Patient-Derived Xenograft Mouse Model by Monoclonal Antibodies against IL-12 p40 Monomer.
Kundu M; Raha S; Roy A; Pahan K
Cells; 2022 Jan; 11(2):. PubMed ID: 35053375
[TBL] [Abstract][Full Text] [Related]
13. γδ T cells bring unconventional cancer-targeting to the clinic - again.
Garber K
Nat Biotechnol; 2020 Apr; 38(4):389-391. PubMed ID: 32265560
[No Abstract] [Full Text] [Related]
14. Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
Cha JH; Chan LC; Wang YN; Chu YY; Wang CH; Lee HH; Xia W; Shyu WC; Liu SP; Yao J; Chang CW; Cheng FR; Liu J; Lim SO; Hsu JL; Yang WH; Hortobagyi GN; Lin C; Yang L; Yu D; Jeng LB; Hung MC
J Biol Chem; 2022 Apr; 298(4):101817. PubMed ID: 35278434
[TBL] [Abstract][Full Text] [Related]
15. Different roles of CD4, CD8 and γδ T-lymphocytes in naive and vaccinated chickens during Salmonella Enteritidis infection.
Sekelova Z; Polansky O; Stepanova H; Fedr R; Faldynova M; Rychlik I; Vlasatikova L
Proteomics; 2017 Jul; 17(13-14):. PubMed ID: 28621911
[TBL] [Abstract][Full Text] [Related]
16. Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast Cancer.
Bagati A; Kumar S; Jiang P; Pyrdol J; Zou AE; Godicelj A; Mathewson ND; Cartwright ANR; Cejas P; Brown M; Giobbie-Hurder A; Dillon D; Agudo J; Mittendorf EA; Liu XS; Wucherpfennig KW
Cancer Cell; 2021 Jan; 39(1):54-67.e9. PubMed ID: 33385331
[TBL] [Abstract][Full Text] [Related]
17. Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer.
Kurozumi S; Fujii T; Matsumoto H; Inoue K; Kurosumi M; Horiguchi J; Kuwano H
Med Mol Morphol; 2017 Dec; 50(4):185-194. PubMed ID: 28936553
[TBL] [Abstract][Full Text] [Related]
18. Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non-Small Cell Lung Cancer: The MYSTIC Phase 3 Randomized Clinical Trial.
Rizvi NA; Cho BC; Reinmuth N; Lee KH; Luft A; Ahn MJ; van den Heuvel MM; Cobo M; Vicente D; Smolin A; Moiseyenko V; Antonia SJ; Le Moulec S; Robinet G; Natale R; Schneider J; Shepherd FA; Geater SL; Garon EB; Kim ES; Goldberg SB; Nakagawa K; Raja R; Higgs BW; Boothman AM; Zhao L; Scheuring U; Stockman PK; Chand VK; Peters S;
JAMA Oncol; 2020 May; 6(5):661-674. PubMed ID: 32271377
[TBL] [Abstract][Full Text] [Related]
19. Pembrolizumab Improves Outcomes in Early-Stage and Locally Advanced or Metastatic Triple-Negative Breast Cancer.
Jacobson A
Oncologist; 2022 Mar; 27(Suppl 1):S17-S18. PubMed ID: 35348777
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of CD4+ T-cells and CD8+ T-cells in triple-negative invasive breast cancer.
Jagtap SV
Indian J Pathol Microbiol; 2018; 61(4):477-478. PubMed ID: 30303132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
